Literature DB >> 18582837

Acute lung injury and other serious complications of Plasmodium vivax malaria.

Lionel K K Tan1, Sophie Yacoub, Sarah Scott, Sanjay Bhagani, Michael Jacobs.   

Abstract

Plasmodium vivax infection is classified among the so-called benign malarias, but it is increasingly recognised that serious and even life-threatening complications may occur. We present the case of a returning traveller with P vivax infection who developed acute lung injury 3 days into treatment, and discuss the serious complications of this infection. The case highlights the fact that P vivax infection is benign by name but not always by nature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582837     DOI: 10.1016/S1473-3099(08)70153-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  33 in total

1.  Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India.

Authors:  Dhanpat Kumar Kochar; Gajanand Singh Tanwar; Poonam Chand Khatri; Sanjay Kumar Kochar; Ghanshyam Singh Sengar; Anjana Gupta; Abhishek Kochar; Sheetal Middha; Jyoti Acharya; Vishal Saxena; Deepak Pakalapati; Shilpi Garg; Ashish Das
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  Role of Plasmodium vivax Dihydropteroate Synthase Polymorphisms in Sulfa Drug Resistance.

Authors:  Wichai Pornthanakasem; Pinpunya Riangrungroj; Penchit Chitnumsub; Wanwipa Ittarat; Darin Kongkasuriyachai; Chairat Uthaipibull; Yongyuth Yuthavong; Ubolsree Leartsakulpanich
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study.

Authors:  Shobha Sharma; Kailash Chandra Aggarwal; Shivani Deswal; Deepak Raut; Neelam Roy; Rohit Kapoor
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 5.  Plasmodium vivax treatments: what are we looking for?

Authors:  Ric N Price; Nicholas M Douglas; Nicholas M Anstey; Lorenz von Seidlein
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

Review 6.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

Review 7.  Imaging Plasmodium immunobiology in the liver, brain, and lung.

Authors:  Ute Frevert; Adéla Nacer; Mynthia Cabrera; Alexandru Movila; Maike Leberl
Journal:  Parasitol Int       Date:  2013-09-27       Impact factor: 2.230

8.  Plasmodium vivax Induced Acute Respiratory Distress Syndrome - A Diagnostic and Therapeutic Dilemma in Preeclampsia.

Authors:  Richa Sharma; Amita Suneja; Anu Yadav; Kiran Guleria
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 9.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

10.  Clinical and laboratory features of human Plasmodium knowlesi infection.

Authors:  Cyrus Daneshvar; Timothy M E Davis; Janet Cox-Singh; Mohammad Zakri Rafa'ee; Siti Khatijah Zakaria; Paul C S Divis; Balbir Singh
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.